Qin Kaiyun, Zhang Fenghua, Wang Hongxia, Wang Na, Qiu Hongbing, Jia Xinzhuan, Gong Shan, Zhang Zhengmao
Department of Gynecology, Fourth Hospital of Hebei Medical University, Hebei Shijiazhuang 050011; Department of Gynecology, Hebei General Hospital, Hebei Shijiazhuang 050057, China.
Department of Breast & Thyroid Surgery, Hebei General Hospital, Hebei Shijiazhuang 050057, China.
BMB Rep. 2024 Feb;57(2):122.
[Erratum to: BMB Reports 2023; 56(3): 184-189, PMID: 36617466, PMCID: PMC10068343] The BMB Reports would like to correct in BMB Rep. 56(3): 184-189, titled "circRNA circSnx12 confers Cisplatin chemoresistance to ovarian cancer by inhibiting ferroptosis through a miR-194-5p/SLC7A11 axis". The original version of this article unfortunately contained image error in the Fig. 3. This article has been updated to correct an error in the image in Fig. 3D. The author apologizes for any inconvenience or confusion this error may cause. Author information has been modified in the original PDF version.
[《BMB报告》勘误：2023年；56(3): 184 - 189，PMID: 36617466，PMCID: PMC10068343]《BMB报告》特此对发表于《BMB报告》56(3): 184 - 189的文章“circRNA circSnx12通过miR - 194 - 5p/SLC7A11轴抑制铁死亡赋予卵巢癌顺铂化疗耐药性”进行勘误。不幸的是，本文原始版本在图3中存在图像错误。本文已更新以纠正图3D中的图像错误。作者对该错误可能造成的任何不便或困惑表示歉意。原始PDF版本中的作者信息已修改。
